NOMAINVEST
The computed 12-month bankruptcy probability of NOMAINVEST is 0.1% (very low). The company has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 29 yrs |
| Board | 10 |
| Locations | 1 |
| Publications | 20 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 25-06-2025 | 2025-00177103 |
| 31-12-2023 | volledig | 20-06-2024 | 2024-00155953 |
| 31-12-2022 | volledig | 26-06-2023 | 2023-00155900 |
| 31-12-2021 | volledig | 23-06-2022 | 2022-20098435 |
| 31-12-2020 | volledig | 02-06-2021 | 2021-17000041 |
| 31-12-2019 | volledig | 12-06-2020 | 2020-16900071 |
| 31-12-2018 | volledig | 18-07-2019 | 2019-34900365 |
| 31-12-2017 | volledig | 27-08-2018 | 2018-53500133 |
| 31-12-2016 | volledig | 23-05-2017 | 2017-13400577 |
| 31-12-2015 | volledig | 09-06-2016 | 2016-16700103 |
-
Maxime WayoffDirectorState Gazette act 25104611 (18-08-2025)Current18-08-2025 → present
-
Wilfried SchöpgesDirectorState Gazette act 24097366 (28-06-2024)Current28-06-2024 → present
-
Cheniclem s.a.DirectorState Gazette act 22131039 (07-11-2022)Current07-11-2022 → present
2 events
- 07-11-2022 Appointed· Director
- 07-11-2022 Appointed· Managing director
-
Cheniclem Private Equity s.a.Legal entityDirector· perm. rep.: Bernard JollyState Gazette act 22069135 (10-06-2022)Current10-06-2022 → present
2 events
- 10-06-2022 Appointed· Director
- 10-06-2022 Appointed· Managing director
-
Noël Management & Finance s.a.Legal entityDirector· perm. rep.: Yves NoëiState Gazette act 22069135 (10-06-2022)Current10-06-2022 → present
-
Good45 srlLegal entityDirectorState Gazette act 21068064 (09-06-2021)Current09-06-2021 → present
-
Liclem srlLegal entityDirectorState Gazette act 21068064 (09-06-2021)Current09-06-2021 → present
-
Vincent Doumier srlLegal entityDirectorState Gazette act 21068064 (09-06-2021)Current09-06-2021 → present
-
Bernard JollyManaging directorState Gazette act 25104611 (18-08-2025)Current07-06-2019 → present
3 events
- 18-08-2025 Appointed· Managing director
- 29-01-2021 Appointed· Managing director
- 07-06-2019 Appointed· Administrator
-
Yves NoëlPrésident du conseil d'administrationState Gazette act 25104611 (18-08-2025)Current07-06-2019 → present
4 events
- 18-08-2025 Appointed· Président du conseil d'administration
- 29-01-2021 Appointed· President du conseil d'administration
- 09-06-2020 Appointed· Managing director
- 07-06-2019 Appointed· Administrator
Historic, not recently confirmed (9)
-
Alexandre JortayDirectorState Gazette act 20064545 (09-06-2020)Not recently confirmedlast confirmed in an act from 2020
-
Pierre-Paul De SchrevelAdministratorState Gazette act 19076580 (07-06-2019)Not recently confirmedlast confirmed in an act from 2019
2 events
- 07-06-2019 Appointed· Administrator
- 23-07-2018 Appointed· Director
-
Vincent DoumierAdministratorState Gazette act 19076580 (07-06-2019)Not recently confirmedlast confirmed in an act from 2019
2 events
- 07-06-2019 Appointed· Administrator
- 23-07-2018 Appointed· Director
-
Deloitte Réviseurs d'entreprises Sc ScrlLegal entityAuditorState Gazette act 17143963 (11-10-2017)Not recently confirmedlast confirmed in an act from 2017
-
M. Baudouin MichielsDirectorState Gazette act 16104621 (26-07-2016)Not recently confirmedlast confirmed in an act from 2016
-
Nopawa s.p.r.l. représentée par good45 s.p.r.l., elle-même représentée par M. Pierre-Paul de SchrevelDirectorState Gazette act 16104621 (26-07-2016)Not recently confirmedlast confirmed in an act from 2016
-
Catherine Schoonbroodt-NoëlAdministratorState Gazette act 15082855 (11-06-2015)Not recently confirmedlast confirmed in an act from 2015
-
Micam s.p.r.l. représentée par M. Alexandre JortayAdministratorState Gazette act 15082855 (11-06-2015)Not recently confirmedlast confirmed in an act from 2015
-
N.M.F. s.a. représentée par M. Yves NoëlAdministratorState Gazette act 15082855 (11-06-2015)Not recently confirmedlast confirmed in an act from 2015
Permanent representatives (2)
-
Carl LaschetRepresentant permanent du commissaire de la sociétéState Gazette act 22131039 (07-11-2022)Permanent representative07-11-2022 → present
-
Laurent WeertsRepresentant permanent du commissaire de la sociétéState Gazette act 22131039 (07-11-2022)Permanent representative- → 07-11-2022
Former directors (7)
-
M. Bernard JollyDirectorState Gazette act 22131039 (07-11-2022)Former- → 07-11-2022
2 events
- 07-11-2022 Resigned· Director
- 07-11-2022 Resigned· Managing director
-
Catherine NoëlDirectorState Gazette act 20064545 (09-06-2020)Former23-07-2018 → 09-06-2021
3 events
- 09-06-2021 Resigned· Director
- 09-06-2020 Appointed· Director
- 23-07-2018 Appointed· Director
-
Baudouin MichielsDirectorState Gazette act 18114513 (23-07-2018)Former- → 23-07-2018
-
Nopawa s.p.r.l. représentée par Madame Dominique NoëlDirectorState Gazette act 16104621 (26-07-2016)Former- → 26-07-2016
-
Madame Catherine Schoonbroodt-NoëlAdministratorState Gazette act 15082855 (11-06-2015)Former- → 11-06-2015
-
Micam s.p.r.l. représentée par Madame Isabelle Jortay-NoëlAdministratorState Gazette act 15082855 (11-06-2015)Former- → 11-06-2015
-
NMF s.a. représentée par Monsieur Yves NoëlAdministratorState Gazette act 15082855 (11-06-2015)Former- → 11-06-2015
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| Laurent Weerts Company auditor |
- | 09-06-2020 → 09-06-2020 |
| SCRL Deloitte Réviseurs d'entreprises représenté par M. Laurent Weerts Commissaire réviseur |
- | 11-06-2015 → 11-06-2015 |
| NACE primary | Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies(70200) |
| Legal form | Public limited company(014) |
| Incorporation | 01-07-1997 |
| Status | Active |
| Postal code | 4700 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
11-08-2026 Act object · Notarial deed · General meeting · Demerger
- Act object: Scission partielle · BePharBel Manufacturing
- Publication: 11/08/2026 · BePharBel Manufacturing
- Filing: 03/08/2026 · BePharBel Manufacturing
- Notarial deed: 10/07/2026 · BePharBel Manufacturing
- General meeting: 10/07/2026 · BePharBel Manufacturing
- Demerger: description: Scission partielle par constitution d'une société anonyme Novaform Pharma. Transfert de la branche d'activités MMCR. · BePharBel Manufacturing
- Net asset statement: date: 31/12/2025, amount: 5720586, currency: EUR · BePharBel Manufacturing
- Capital decrease: after: 7664142.35, delta: -4238390, amount: 7664142.35, before: 11902532.35, currency: EUR · BePharBel Manufacturing
- Capital: amount: 7664142.35, shares: 996268, currency: EUR · BePharBel Manufacturing
- Share issue: count: 996268, description: Actions entièrement libérées attribuées aux actionnaires de la société scindée · Novaform Pharma
- Share transfer: count: 63640, percentage: 6,39% · BePharBel Manufacturing
- Share transfer: count: 176726, percentage: 17,74% · BePharBel Manufacturing
- Share transfer: count: 86890, percentage: 8,72% · BePharBel Manufacturing
- Share transfer: count: 210832, percentage: 21,16% · BePharBel Manufacturing
- Share transfer: count: 58483, percentage: 5,87% · BePharBel Manufacturing
- Share transfer: count: 3746, percentage: 0,38% · BePharBel Manufacturing
- Share transfer: count: 3829, percentage: 0,38% · BePharBel Manufacturing
- Share transfer: count: 252041, percentage: 25,30% · BePharBel Manufacturing
- Share transfer: count: 140081, percentage: 14,06% · BePharBel Manufacturing
- Power of attorney: Pouvoirs les plus étendus aux fins de veiller au déroulement des opérations de scission partielle et à l'application des effets légaux de cette scission. · Julia PIEKUNKO
- Permanent representative · Gery LEFEBVRE
- Mandate compensation: gratuit · Philippe NIESSEN
- Mandate compensation: gratuit · SPARAXIS
- Power of attorney: Tous pouvoirs pour l'exécution des résolutions et accomplir les formalités nécessaires auprès de toutes administrations compétentes. · Benoît COLMANT
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Scission partielle",
"value": "Scission partielle",
"object": null,
"subject": "e1"
},
{
"date": "2026-08-11",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 11/08/2026 - Annexes du Moniteur belge",
"value": "11/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-08-03",
"type": "filing",
"quote": "03 AOUT 2026",
"value": "03/08/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-10",
"type": "notarial_deed",
"quote": "D\u0027un proc\u00E8s-verbal dress\u00E9 par Edouard-Jean NAVEZ, notaire associ\u00E9 \u00E0 la r\u00E9sidence de Grez-Doiceau le 10 juillet 2026",
"value": "10/07/2026",
"object": "e3",
"subject": "e1"
},
{
"date": "2026-07-10",
"type": "general_meeting",
"quote": "D\u0027un proc\u00E8s-verbal dress\u00E9 par Edouard-Jean NAVEZ, notaire associ\u00E9 \u00E0 la r\u00E9sidence de Grez-Doiceau le 10 juillet 2026 ... il r\u00E9sulte que l\u0027assembl\u00E9e de la soci\u00E9t\u00E9 anonyme \u00AB BePharBel Manufacturing \u00BB a pris les r\u00E9solutions",
"value": "10/07/2026",
"object": null,
"subject": "e1"
},
{
"type": "demerger",
"quote": "L\u0027assembl\u00E9e d\u00E9cide ... la scission partielle de la pr\u00E9sente soci\u00E9t\u00E9 par constitution d\u0027une soci\u00E9t\u00E9 anonyme \u003C Novaform Pharma \u00BB ... Cette scission partielle aura pour effet l\u0027apport de la branche d\u0027activit\u00E9s MMCR",
"value": {
"description": "Scission partielle par constitution d\u0027une soci\u00E9t\u00E9 anonyme Novaform Pharma. Transfert de la branche d\u0027activit\u00E9s MMCR."
},
"object": "e2",
"subject": "e1"
},
{
"date": "2025-12-31",
"type": "net_asset_statement",
"quote": "Ce transfert comprend, sur base de la situation arr\u00EAt\u00E9e au 31 d\u00E9cembre 2025 ... Total 5.720.586 EUR",
"value": {
"date": "31/12/2025",
"amount": 5720586,
"currency": "EUR"
},
"amount": 5720586.0,
"object": null,
"subject": "e1",
"currency": "EUR"
},
{
"type": "capital_decrease",
"quote": "l\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital de la soci\u00E9t\u00E9 \u00E0 concurrence de 4.238.390 euros pour le ramener de 11.902.532,35 euros \u00E0 7.664.142,35 euros sans annulation de titres.",
"value": {
"after": 7664142.35,
"delta": -4238390,
"amount": 7664142.35,
"before": 11902532.35,
"currency": "EUR"
},
"amount": -4238390.0,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"after": 7664142.35,
"delta": -4238390,
"before": 11902532.35,
"currency": "EUR"
}
},
{
"type": "capital",
"quote": "ARTICLE 5- CAPITAL Le capital est fix\u00E9 \u00E0 7.664.142,35 EUR. Il est repr\u00E9sent\u00E9 par 996.268 actions",
"value": {
"amount": 7664142.35,
"shares": 996268,
"currency": "EUR"
},
"amount": 7664142.35,
"object": null,
"subject": "e1",
"currency": "EUR"
},
{
"type": "share_issue",
"quote": "En r\u00E9mun\u00E9ration de ce transfert. il sera attribu\u00E9 imm\u00E9diatement et directement aux actionnaires 996.268 actions enti\u00E8rement lib\u00E9r\u00E9es de la soci\u00E9t\u00E9 b\u00E9n\u00E9ficiaire.",
"value": {
"count": 996268,
"description": "Actions enti\u00E8rement lib\u00E9r\u00E9es attribu\u00E9es aux actionnaires de la soci\u00E9t\u00E9 scind\u00E9e"
},
"object": null,
"subject": "e2"
},
{
"type": "share_transfer",
"quote": "Sambrinvest Spin-Off/Spin-Out SA ... 63.640 6,39%",
"value": {
"count": 63640,
"percentage": "6,39%"
},
"object": "e4",
"subject": "e1"
},
{
"type": "share_transfer",
"quote": "Iris Belgium SRL ... 176.726 17.74%",
"value": {
"count": 176726,
"percentage": "17,74%"
},
"object": "e5",
"subject": "e1"
},
{
"type": "share_transfer",
"quote": "Talence SA ... 86.890 8,72%",
"value": {
"count": 86890,
"percentage": "8,72%"
},
"object": "e6",
"subject": "e1"
},
{
"type": "share_transfer",
"quote": "Vinsovier Soci\u00E9t\u00E9 simple ... 210.832 21,16%",
"value": {
"count": 210832,
"percentage": "21,16%"
},
"object": "e7",
"subject": "e1"
},
{
"type": "share_transfer",
"quote": "CANA Soci\u00E9t\u00E9 simple ... 58.483 5,87%",
"value": {
"count": 58483,
"percentage": "5,87%"
},
"object": "e8",
"subject": "e1"
},
{
"type": "share_transfer",
"quote": "Monsieur Georges Guillaume ... 3.746 0,38%",
"value": {
"count": 3746,
"percentage": "0,38%"
},
"object": "e9",
"subject": "e1"
},
{
"type": "share_transfer",
"quote": "Monsieur Pascal Lizin ... 3.829 0,38%",
"value": {
"count": 3829,
"percentage": "0,38%"
},
"object": "e10",
"subject": "e1"
},
{
"type": "share_transfer",
"quote": "Nomainvest SA ... 252.041 25,30%",
"value": {
"count": 252041,
"percentage": "25,30%"
},
"object": "e11",
"subject": "e1"
},
{
"type": "share_transfer",
"quote": "Wallonie Entreprendre ... 140.081 14.06%",
"value": {
"count": 140081,
"percentage": "14,06%"
},
"object": "e12",
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e conf\u00E8re \u00E0 Madame Julia PIEKUNKO, pr\u00E9qualifi\u00E9e, les pouvoirs les plus \u00E9tendus aux fins de veiller au d\u00E9roulement des op\u00E9rations de scission partielle...",
"value": "Pouvoirs les plus \u00E9tendus aux fins de veiller au d\u00E9roulement des op\u00E9rations de scission partielle et \u00E0 l\u0027application des effets l\u00E9gaux de cette scission.",
"object": "e1",
"subject": "e13"
},
{
"type": "permanent_representative",
"quote": "La SA SPARAXIS ... laquelle d\u00E9signe en qualit\u00E9 de repr\u00E9sentant permanent, Monsieur LEFEBVRE Gery...",
"value": null,
"object": "e19",
"subject": "e20"
},
{
"type": "mandate_compensation",
"quote": "Leur mandat est gratuit.",
"value": "gratuit",
"object": null,
"subject": "e18"
},
{
"type": "mandate_compensation",
"quote": "Leur mandat est gratuit.",
"value": "gratuit",
"object": null,
"subject": "e19"
},
{
"type": "power_of_attorney",
"quote": "L\u0027assembl\u00E9e conf\u00E8re \u00E0 l\u0027unanimit\u00E9 tous pouvoirs aux administrateurs et au notaire soussign\u00E9 ... pour l\u0027ex\u00E9cution des r\u00E9solutions qui pr\u00E9c\u00E8dent et, notamment, pour accomplir les formalit\u00E9s n\u00E9cessaires...",
"value": "Tous pouvoirs pour l\u0027ex\u00E9cution des r\u00E9solutions et accomplir les formalit\u00E9s n\u00E9cessaires aupr\u00E8s de toutes administrations comp\u00E9tentes.",
"object": "e1",
"subject": "e21"
}
],
"act_meta": {
"outcome": "review",
"postfix": [
"proposal act: dropped 5 restated officer fact(s)"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 29914,
"truncated": false,
"lengthcap_fallback": [
"verify:budget2000"
]
},
"entities": [
{
"id": "e1",
"kbo": "0844.689.955",
"kind": "company",
"name": "BePharBel Manufacturing",
"attrs": {
"seat": "6180 Courcelles, rue du Luxembourg 13",
"legal_form": "SA"
}
},
{
"id": "e2",
"kbo": null,
"kind": "company",
"name": "Novaform Pharma",
"attrs": {
"seat": "6180 Courcelles, rue du Luxembourg 13",
"legal_form": "SA"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Edouard-Jean NAVEZ",
"attrs": {}
},
{
"id": "e4",
"kbo": "0884.341.575",
"kind": "company",
"name": "Sambrinvest Spin-Off/Spin-Out SA",
"attrs": {}
},
{
"id": "e5",
"kbo": "0540.792.024",
"kind": "company",
"name": "Iris Belgium SRL",
"attrs": {}
},
{
"id": "e6",
"kbo": "0841.369.288",
"kind": "company",
"name": "Talence SA",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "company",
"name": "Vinsovier Soci\u00E9t\u00E9 simple",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "company",
"name": "CANA Soci\u00E9t\u00E9 simple",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Georges Guillaume",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Pascal Lizin",
"attrs": {}
},
{
"id": "e11",
"kbo": "0460.996.458",
"kind": "company",
"name": "Nomainvest SA",
"attrs": {}
},
{
"id": "e12",
"kbo": "0793.630.244",
"kind": "company",
"name": "Wallonie Entreprendre",
"attrs": {}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Julia PIEKUNKO",
"attrs": {}
},
{
"id": "e14",
"kbo": "0841.369.288",
"kind": "company",
"name": "Talence SA",
"attrs": {}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Jean-Jacques DELENS",
"attrs": {}
},
{
"id": "e16",
"kbo": null,
"kind": "person",
"name": "Cyril WOLKONSKI",
"attrs": {}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Yves-G\u00E9rard NOEL",
"attrs": {}
},
{
"id": "e18",
"kbo": null,
"kind": "person",
"name": "Philippe NIESSEN",
"attrs": {
"address": "4701 Eupen, Zur Nohn, 24",
"birth_date": "1990-05-27",
"birth_place": "Eupen"
}
},
{
"id": "e19",
"kbo": "0452.116.307",
"kind": "company",
"name": "SPARAXIS",
"attrs": {
"seat": "4000 Li\u00E8ge, avenue Maurice-Destenay 13"
}
},
{
"id": "e20",
"kbo": null,
"kind": "person",
"name": "Gery LEFEBVRE",
"attrs": {
"address": "4000 Li\u00E8ge, Quai de Rome, 46/0021",
"birth_date": "1972-12-28",
"birth_place": "Ch\u00EAn\u00E9e"
}
},
{
"id": "e21",
"kbo": null,
"kind": "person",
"name": "Beno\u00EEt COLMANT",
"attrs": {}
}
]
}15-07-2026 Act object · Notarial deed · Incorporation · Demerger
- Act object: CONSTITUTION · NOVAFORM PHARMA
- Publication: 15/07/2026 · NOVAFORM PHARMA
- Filing: 13-07-2026 · NOVAFORM PHARMA
- Notarial deed: 10 juillet 2026 · NOVAFORM PHARMA
- Incorporation: 10 juillet 2026 · NOVAFORM PHARMA
- Demerger: date: 10 juillet 2026, type: scission partielle par constitution de société nouvelle · BEPHARBEL MANUFACTURING
- Founder · BEPHARBEL MANUFACTURING
- Power of attorney: veiller au déroulement des opérations de scission et à l’application des effets légaux de cette scission · Julia PIEKUNKO
- Purpose: La société a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et à l'étranger, la recherche, le développement, la mise au point, la fabrication, la production, l'industrie, l'achat, la vente, le conditionnement, l'importation et l'exportation, et la transformation : de tous produits chimiques, pharmaceutiques, biologiques, biotechnologiques, de thérapie avancée, ainsi que tous les produits de santé, diagnostics, dispositifs médicaux, vétérinaires et plus généralement de tous les produits se rapportant directement ou indirectement aux sciences de la vie ; de tous produits intermédiaires, substances actives, matières premières, composants, consommables et dérivés utiles ou nécessaires aux activités susmentionnées ; de tous équipements, installations, technologies, procédés, systèmes et accessoires liés aux activités de recherche, développement, production, conditionnement, contrôle qualité et commercialisation des produits et articles repris ci-dessus ; la prestation de tous services scientifiques, techniques, industriels et réglementaires, notamment dans le cadre d’activités de type développement de procédés, transfert de technologies, fabrication pour compte de tiers (CDMO/CMO), recherche contractuelle (CRO), analyses, contrôle qualité, assurance qualité, validation, qualification et conformité réglementaire ; Le développement, l’exploitation et la commercialisation d’équipements, plateformes technologiques, procédés, méthodes, et d’accessoires relatifs aux activités de recherche, développement, production et commercialisation des produits et articles repris ci-dessus ; La vente de tous livres ou supports papier ou électronique en rapport avec son objet; et en général toutes activités intéressant l'approvisionnement de l'industrie chimique, pharmaceutique, biotechnologique, des hôpitaux et cliniques, des officines pharmaceutiques et drogueries, laboratoires et institutions de recherche, ainsi que des matières et produits similaires et connexes. La société peut de manière générale, entreprendre toutes opérations de commerce, d'industrie et de finance, mobilières et immobilières, dans toutes entreprises dont l'objet se rattache directement ou indirectement à son industrie ou son commerce/ en tout ou en partie à son objet ou qui seraient de nature à en faciliter ou à développer la réalisation/ La société peut également exercer toute activité d'ingénieur conseil, de bureau d'études, de conception ou réalisation d'appareils ou d'entreprises publique ou privée- y compris l'organisation-rien excepté ni réservé. La société peut s'intéresser par voie d'apport, de fusion, de souscription, d'association, de cession, ou achat de titres ou droits sociaux, ou de toute autre manière dans toutes sociétés, entreprises ou associations existantes ou à créer en Belgique ou à l'étranger, dont l'objet se rattache directement ou indirectement à son industrie ou son commerce/ à son objet ou simplement susceptible d'accroitre son activité sociale. La société pourra acquérir, développer, exploiter, concéder ou céder des brevets ou licences ayant trait, directement ou indirectement, aux opérations se rapportant à l'objet. · NOVAFORM PHARMA
- Founding capital: amount: 4238390.0, shares: 996268, currency: EUR · NOVAFORM PHARMA
- Share issue: count: 63640, percentage: 6,39% · NOVAFORM PHARMA
- Share issue: count: 176726, percentage: 17,74% · NOVAFORM PHARMA
- Share issue: count: 86890, percentage: 8,72% · NOVAFORM PHARMA
- Share issue: count: 210832, percentage: 21,16% · NOVAFORM PHARMA
- Share issue: count: 58483, percentage: 5,87% · NOVAFORM PHARMA
- Share issue: count: 3746, percentage: 0,38% · NOVAFORM PHARMA
- Share issue: count: 3829, percentage: 0,38% · NOVAFORM PHARMA
- Share issue: count: 252041, percentage: 25,30% · NOVAFORM PHARMA
- Share issue: count: 140081, percentage: 14,06% · NOVAFORM PHARMA
- Net asset statement: date: 31 décembre 2025, amount: 5720586, currency: EUR · BEPHARBEL MANUFACTURING
- Accounting effect: 31 décembre 2025 · NOVAFORM PHARMA
- Pledge: CBC Banque, ING et BNP Paribas Fortis · BEPHARBEL MANUFACTURING
- Auditor report: 25 juin 2026 · NOVAFORM PHARMA
- Publication: 20260526-067087 · BEPHARBEL MANUFACTURING
- Duration: illimitée · NOVAFORM PHARMA
- Board composition: 9 · NOVAFORM PHARMA
- Representation: deux administrateurs agissant conjointement · NOVAFORM PHARMA
- Auditor: un ou plusieurs commissaires · NOVAFORM PHARMA
- Real estate declaration: aucun immeuble · BEPHARBEL MANUFACTURING
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte : CONSTITUTION",
"value": "CONSTITUTION",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-15",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 15/07/2026 - Annexes du Moniteur belge",
"value": "15/07/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-13",
"type": "filing",
"quote": "D\u00E9pos\u00E9 13-07-2026",
"value": "13-07-2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-10",
"type": "notarial_deed",
"quote": "Extrait de l\u2019acte constitutif re\u00E7u par Edouard-Jean NAVEZ, notaire associ\u00E9 \u00E0 la r\u00E9sidence de Grez-Doiceau, en date du 10 juillet 2026",
"value": "10 juillet 2026",
"object": "e3",
"subject": "e1"
},
{
"date": "2026-07-10",
"type": "incorporation",
"quote": "La soci\u00E9t\u00E9 comparante requiert le notaire soussign\u00E9 d\u2019acter que suite \u00E0 la d\u00E9cision de scission partielle, une soci\u00E9t\u00E9 anonyme \u00AB NOVAFORM PHARMA \u00BB est constitu\u00E9e",
"value": "10 juillet 2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-07-10",
"type": "demerger",
"quote": "la scission sera r\u00E9alis\u00E9e, sans que la soci\u00E9t\u00E9 cesse d\u2019exister, par transfert d\u2019une partie de son patrimoine actif et passif \u00E0 la pr\u00E9sente soci\u00E9t\u00E9 anonyme qu\u2019elle constitue",
"value": {
"date": "10 juillet 2026",
"type": "scission partielle par constitution de soci\u00E9t\u00E9 nouvelle"
},
"object": "e1",
"subject": "e2"
},
{
"type": "founder",
"quote": "FONDATEUR \u0022BEPHARBEL MANUFACTURING\u0022 soci\u00E9t\u00E9 anonyme",
"value": null,
"object": "e1",
"subject": "e2"
},
{
"type": "power_of_attorney",
"quote": "la soci\u00E9t\u00E9 scind\u00E9e partiellement sera repr\u00E9sent\u00E9e par Madame Julia PIEKUNKO. Les pouvoirs les plus \u00E9tendus ont \u00E9t\u00E9 conf\u00E9r\u00E9s au mandataire ci-avant d\u00E9sign\u00E9 aux fins de veiller au d\u00E9roulement des op\u00E9rations de scission",
"value": "veiller au d\u00E9roulement des op\u00E9rations de scission et \u00E0 l\u2019application des effets l\u00E9gaux de cette scission",
"object": "e2",
"subject": "e6"
},
{
"type": "purpose",
"quote": "ARTICLE 3 \u2013 OBJET",
"value": "La soci\u00E9t\u00E9 a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et \u00E0 l\u0027\u00E9tranger, la recherche, le d\u00E9veloppement, la mise au point, la fabrication, la production, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation et l\u0027exportation, et la transformation : de tous produits chimiques, pharmaceutiques, biologiques, biotechnologiques, de th\u00E9rapie avanc\u00E9e, ainsi que tous les produits de sant\u00E9, diagnostics, dispositifs m\u00E9dicaux, v\u00E9t\u00E9rinaires et plus g\u00E9n\u00E9ralement de tous les produits se rapportant directement ou indirectement aux sciences de la vie ; de tous produits interm\u00E9diaires, substances actives, mati\u00E8res premi\u00E8res, composants, consommables et d\u00E9riv\u00E9s utiles ou n\u00E9cessaires aux activit\u00E9s susmentionn\u00E9es ; de tous \u00E9quipements, installations, technologies, proc\u00E9d\u00E9s, syst\u00E8mes et accessoires li\u00E9s aux activit\u00E9s de recherche, d\u00E9veloppement, production, conditionnement, contr\u00F4le qualit\u00E9 et commercialisation des produits et articles repris ci-dessus ; la prestation de tous services scientifiques, techniques, industriels et r\u00E9glementaires, notamment dans le cadre d\u2019activit\u00E9s de type d\u00E9veloppement de proc\u00E9d\u00E9s, transfert de technologies, fabrication pour compte de tiers (CDMO/CMO), recherche contractuelle (CRO), analyses, contr\u00F4le qualit\u00E9, assurance qualit\u00E9, validation, qualification et conformit\u00E9 r\u00E9glementaire ; Le d\u00E9veloppement, l\u2019exploitation et la commercialisation d\u2019\u00E9quipements, plateformes technologiques, proc\u00E9d\u00E9s, m\u00E9thodes, et d\u2019accessoires relatifs aux activit\u00E9s de recherche, d\u00E9veloppement, production et commercialisation des produits et articles repris ci-dessus ; La vente de tous livres ou supports papier ou \u00E9lectronique en rapport avec son objet; et en g\u00E9n\u00E9ral toutes activit\u00E9s int\u00E9ressant l\u0027approvisionnement de l\u0027industrie chimique, pharmaceutique, biotechnologique, des h\u00F4pitaux et cliniques, des officines pharmaceutiques et drogueries, laboratoires et institutions de recherche, ainsi que des mati\u00E8res et produits similaires et connexes. La soci\u00E9t\u00E9 peut de mani\u00E8re g\u00E9n\u00E9rale, entreprendre toutes op\u00E9rations de commerce, d\u0027industrie et de finance, mobili\u00E8res et immobili\u00E8res, dans toutes entreprises dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce/ en tout ou en partie \u00E0 son objet ou qui seraient de nature \u00E0 en faciliter ou \u00E0 d\u00E9velopper la r\u00E9alisation/ La soci\u00E9t\u00E9 peut \u00E9galement exercer toute activit\u00E9 d\u0027ing\u00E9nieur conseil, de bureau d\u0027\u00E9tudes, de conception ou r\u00E9alisation d\u0027appareils ou d\u0027entreprises publique ou priv\u00E9e- y compris l\u0027organisation-rien except\u00E9 ni r\u00E9serv\u00E9. La soci\u00E9t\u00E9 peut s\u0027int\u00E9resser par voie d\u0027apport, de fusion, de souscription, d\u0027association, de cession, ou achat de titres ou droits sociaux, ou de toute autre mani\u00E8re dans toutes soci\u00E9t\u00E9s, entreprises ou associations existantes ou \u00E0 cr\u00E9er en Belgique ou \u00E0 l\u0027\u00E9tranger, dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce/ \u00E0 son objet ou simplement susceptible d\u0027accroitre son activit\u00E9 sociale. La soci\u00E9t\u00E9 pourra acqu\u00E9rir, d\u00E9velopper, exploiter, conc\u00E9der ou c\u00E9der des brevets ou licences ayant trait, directement ou indirectement, aux op\u00E9rations se rapportant \u00E0 l\u0027objet.",
"object": null,
"subject": "e1"
},
{
"type": "founding_capital",
"quote": "Le capital est fix\u00E9 \u00E0 4.238.390 EUR. Il est repr\u00E9sent\u00E9 par 996.268 actions sans d\u00E9signation de valeur nominale",
"value": {
"amount": 4238390.0,
"shares": 996268,
"currency": "EUR"
},
"amount": 4238390.0,
"object": null,
"subject": "e1",
"currency": "EUR",
"_value_raw": {
"amount": "4.238.390",
"shares": 996268,
"currency": "EUR"
}
},
{
"type": "share_issue",
"quote": "Sambrinvest Spin-Off/Spin-Out SA (BCE 0884.341.575) 63.640 6,39%",
"value": {
"count": 63640,
"percentage": "6,39%"
},
"object": "e7",
"subject": "e1"
},
{
"type": "share_issue",
"quote": "Iris Belgium SRL (BCE 0540.792.024) 176.726 17,74%",
"value": {
"count": 176726,
"percentage": "17,74%"
},
"object": "e8",
"subject": "e1"
},
{
"type": "share_issue",
"quote": "Talence SA (BCE 0841.369.288) 86.890 8,72%",
"value": {
"count": 86890,
"percentage": "8,72%"
},
"object": "e9",
"subject": "e1"
},
{
"type": "share_issue",
"quote": "Vinsovier Soci\u00E9t\u00E9 simple 210.832 21,16%",
"value": {
"count": 210832,
"percentage": "21,16%"
},
"object": "e10",
"subject": "e1"
},
{
"type": "share_issue",
"quote": "CANA Soci\u00E9t\u00E9 simple 58.483 5,87%",
"value": {
"count": 58483,
"percentage": "5,87%"
},
"object": "e11",
"subject": "e1"
},
{
"type": "share_issue",
"quote": "Monsieur Georges Guillaume 3.746 0,38%",
"value": {
"count": 3746,
"percentage": "0,38%"
},
"object": "e12",
"subject": "e1"
},
{
"type": "share_issue",
"quote": "Monsieur Pascal Lizin 3.829 0,38%",
"value": {
"count": 3829,
"percentage": "0,38%"
},
"object": "e13",
"subject": "e1"
},
{
"type": "share_issue",
"quote": "Nomainvest SA (BCE 0460.996.458) 252.041 25,30%",
"value": {
"count": 252041,
"percentage": "25,30%"
},
"object": "e14",
"subject": "e1"
},
{
"type": "share_issue",
"quote": "Wallonie Entreprendre (BCE 0793.630.244) 140.081 14,06%",
"value": {
"count": 140081,
"percentage": "14,06%"
},
"object": "e15",
"subject": "e1"
},
{
"date": "2025-12-31",
"type": "net_asset_statement",
"quote": "Total 5.720.586 EUR ... suite \u00E0 l\u2019apport d\u2019une partie du patrimoine actif et passif de la soci\u00E9t\u00E9 scind\u00E9e \u00E0 la valeur pour laquelle ces \u00E9l\u00E9ments d\u2019actif et de passif figuraient dans la comptabilit\u00E9 de la soci\u00E9t\u00E9 scind\u00E9e au 31 d\u00E9cembre 2025",
"value": {
"date": "31 d\u00E9cembre 2025",
"amount": 5720586,
"currency": "EUR"
},
"amount": 5720586.0,
"object": null,
"subject": "e2",
"currency": "EUR"
},
{
"date": "2025-12-31",
"type": "accounting_effect",
"quote": "Les \u00E9l\u00E9ments du patrimoine de la soci\u00E9t\u00E9 scind\u00E9e sont transf\u00E9r\u00E9s sur base de la situation comptable arr\u00EAt\u00E9e \u00E0 la date du 31 d\u00E9cembre 2025.",
"value": "31 d\u00E9cembre 2025",
"object": null,
"subject": "e1"
},
{
"type": "pledge",
"quote": "La soci\u00E9t\u00E9 comparante d\u00E9clare que le fonds de commerce objet de la scission fait l\u2019objet de trois gages au profit des banques, CBC Banque, ING et BNP Paribas Fortis.",
"value": "CBC Banque, ING et BNP Paribas Fortis",
"object": null,
"subject": "e2"
},
{
"date": "2026-06-25",
"type": "auditor_report",
"quote": "Ce rapport dat\u00E9 du 25 juin 2026, conclut dans les termes suivants :",
"value": "25 juin 2026",
"object": "e4",
"subject": "e1"
},
{
"date": "2026-07-15",
"type": "publication",
"quote": "publi\u00E9 aux annexes du Moniteur belge sous date et num\u00E9ro 20260526-067087",
"value": "20260526-067087",
"object": null,
"subject": "e2"
},
{
"type": "duration",
"quote": "La soci\u00E9t\u00E9 est constitu\u00E9e pour une dur\u00E9e illimit\u00E9e.",
"value": "illimit\u00E9e",
"object": null,
"subject": "e1"
},
{
"type": "board_composition",
"quote": "La soci\u00E9t\u00E9 est administr\u00E9e par un Conseil d\u2019Administration compos\u00E9 de neuf (9) membres au plus",
"value": "9",
"object": null,
"subject": "e1"
},
{
"type": "representation",
"quote": "La soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e dans tous ses actes, en ce compris la repr\u00E9sentation en justice, par deux administrateurs agissant conjointement",
"value": "deux administrateurs agissant conjointement",
"object": null,
"subject": "e1"
},
{
"type": "auditor",
"quote": "Le contr\u00F4le de la situation financi\u00E8re, des comptes annuels et de la r\u00E9gularit\u00E9, au regard du Code des soci\u00E9t\u00E9s et des associations et des statuts, des op\u00E9rations \u00E0 constater dans les comptes annuels, est confi\u00E9 \u00E0 un ou plusieurs commissaires nomm\u00E9s par l\u0027assembl\u00E9e g\u00E9n\u00E9rale",
"value": "un ou plusieurs commissaires",
"object": null,
"subject": "e1"
},
{
"type": "real_estate_declaration",
"quote": "La soci\u00E9t\u00E9 comparante, apr\u00E8s avoir entendu lecture de tout ce qui pr\u00E9c\u00E8de, d\u00E9clare que dans le patrimoine actif et passif transf\u00E9r\u00E9 par la soci\u00E9t\u00E9 anonyme \u00AB BEPHARBEL MANUFACTURING \u00BB \u00E0 la pr\u00E9sente soci\u00E9t\u00E9 ne se trouve compris aucun immeuble.",
"value": "aucun immeuble",
"object": null,
"subject": "e2"
}
],
"act_meta": {
"outcome": "corrected",
"postfix": [
"publication date None -\u003E edition 2026-07-15",
"primary company kbo missing -\u003E register 1040.218.595"
],
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 84001,
"truncated": true
},
"entities": [
{
"id": "e1",
"kbo": "1040.218.595",
"kind": "company",
"name": "NOVAFORM PHARMA",
"attrs": {
"seat": "Rue du Luxembourg 13, 6180 Courcelles",
"kbo_source": "register",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": "0844.689.955",
"kind": "company",
"name": "BEPHARBEL MANUFACTURING",
"attrs": {
"seat": "6180 Courcelles, Rue du Luxembourg 13",
"legal_form": "soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Edouard-Jean NAVEZ",
"attrs": {
"role": "notaire associ\u00E9"
}
},
{
"id": "e4",
"kbo": null,
"kind": "company",
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
"attrs": {
"legal_form": "SRL"
}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Julie Delforge",
"attrs": {
"role": "r\u00E9viseur d\u0027entreprises"
}
},
{
"id": "e6",
"kbo": null,
"kind": "person",
"name": "Julia PIEKUNKO",
"attrs": {}
},
{
"id": "e7",
"kbo": "0884.341.575",
"kind": "company",
"name": "Sambrinvest Spin-Off/Spin-Out SA",
"attrs": {}
},
{
"id": "e8",
"kbo": "0540.792.024",
"kind": "company",
"name": "Iris Belgium SRL",
"attrs": {}
},
{
"id": "e9",
"kbo": "0841.369.288",
"kind": "company",
"name": "Talence SA",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "company",
"name": "Vinsovier Soci\u00E9t\u00E9 simple",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "company",
"name": "CANA Soci\u00E9t\u00E9 simple",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Georges Guillaume",
"attrs": {}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Pascal Lizin",
"attrs": {}
},
{
"id": "e14",
"kbo": "0460.996.458",
"kind": "company",
"name": "Nomainvest SA",
"attrs": {}
},
{
"id": "e15",
"kbo": "0793.630.244",
"kind": "company",
"name": "Wallonie Entreprendre",
"attrs": {}
}
]
}26-05-2026 Merger · Incorporation · Capital increase · Share distribution
- Filing: 2026-05-15 · BEPHARBEL MANUFACTURING
- Merger: date: 2026-05-13, type: scission partielle par constitution d'une nouvelle sociétéproposed · BEPHARBEL MANUFACTURING
- Incorporation: date: 2026-05-13, seat: Rue du Luxembourg 13, 6180 Courcelles, legal_form: Société anonymeproposed · NOVAFORM PHARMA
- Capital increase: shares: 996268, share_type: actions nouvelles sans désignation de valeur nominaleproposed · NOVAFORM PHARMA
- Share distribution: shares: 63640, percentage: 6.39%proposed · NOVAFORM PHARMA
- Share distribution: shares: 176726, percentage: 17,74%proposed · NOVAFORM PHARMA
- Share distribution: shares: 86890, percentage: 8,72%proposed · NOVAFORM PHARMA
- Share distribution: shares: 210832, percentage: 21,16%proposed · NOVAFORM PHARMA
- Share distribution: shares: 58483, percentage: 5,87%proposed · NOVAFORM PHARMA
- Share distribution: shares: 3746, percentage: 0,38%proposed · NOVAFORM PHARMA
- Share distribution: shares: 3829, percentage: 0.38%proposed · NOVAFORM PHARMA
- Share distribution: shares: 252041, percentage: 25,30%proposed · NOVAFORM PHARMA
- Share distribution: shares: 140081, percentage: 14,06%proposed · NOVAFORM PHARMA
- Accounting effect: 2026-01-01proposed · NOVAFORM PHARMA
- Power of attorney: date: 2026-05-13, scope: déposer le projet de scission et l'ensemble des documents requis au greffe du Tribunal de l'entreprise du Hainaut ainsi que de faire l'ensemble des formalités nécessaires à la publication au Moniteur belgeproposed · BEPHARBEL MANUFACTURING
- Power of attorney: date: 2026-05-13, scope: déposer le projet de scission et l'ensemble des documents requis au greffe du Tribunal de l'entreprise du Hainaut ainsi que de faire l'ensemble des formalités nécessaires à la publication au Moniteur belgeproposed · BEPHARBEL MANUFACTURING
- Approval: type: assemblée générale des actionnaires, deadline: 2026-07-15proposed · BEPHARBEL MANUFACTURING
- Incorporation: date: 2012-03-20, notary: Jean-Philippe Matagneproposed · BEPHARBEL MANUFACTURING
- Statute amendment: date: 2026-05-05, notary: Edouard-Jean Navezproposed · BEPHARBEL MANUFACTURING
- Publication: 2026-05-26
- Purpose: tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et à l'étranger, la recherche, la fabrication, l'industrie, l'achat, la vente, le conditionnement, l'importation et l'exportation, et la transformation: -de tous produits chimiques, pharmaceutiques, diététiques, phytopharmaceutiques, homéopathiques, vétérinaires et d'herboristerie; -de tous articles de droguerie en général, de parfumerie, de cosmétiques, d'hygiène et d'entretien; -d'accessoires médicaux et chirurgicaux, d'acoustique, d'optique, d'orthopédie et de bandages; de tous autres produits se rapproposed
- Act object: Projet de scission partielle par constitution d'une nouvelle société
Technical details
{
"facts": [
{
"type": "filing",
"quote": "15 MAI 2026",
"value": "2026-05-15",
"object": null,
"subject": "e1"
},
{
"type": "merger",
"quote": "Objet de l\u0027acte: Projet de scission partielle par constitution d\u0027une nouvelle soci\u00E9t\u00E9",
"value": {
"date": "2026-05-13",
"type": "scission partielle par constitution d\u0027une nouvelle soci\u00E9t\u00E9"
},
"object": "e2",
"subject": "e1",
"proposed": true
},
{
"type": "incorporation",
"quote": "La soci\u00E9t\u00E9 nouvelle issue de la scission sera d\u00E9nomm\u00E9e \u00AB NOVAFORM PHARMA \u00BB. Elle adoptera la forme juridique d\u0027une soci\u00E9t\u00E9 anonyme. Son si\u00E8ge sera \u00E9tabli Rue du Luxembourg, 13 \u00E0 6180 Courcelles.",
"value": {
"date": "2026-05-13",
"seat": "Rue du Luxembourg 13, 6180 Courcelles",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"object": null,
"subject": "e2",
"proposed": true
},
{
"type": "capital_increase",
"quote": "En r\u00E9mun\u00E9ration du transfert du patrimoine c\u00E9d\u00E9, 996.268 actions nouvelles sans d\u00E9signation de valeur nominale seront \u00E9mises au total par NOVAFORM PHARMA.",
"value": {
"shares": 996268,
"capital": {
"amount": 4238390,
"currency": "EUR"
},
"share_type": "actions nouvelles sans d\u00E9signation de valeur nominale",
"share_premium": {
"amount": 2331154,
"currency": "EUR"
}
},
"object": null,
"subject": "e2",
"proposed": true
},
{
"type": "share_distribution",
"quote": "Sambrinvest Spin-Off/Spin-Out SA (BCE 0884.341.575) 63.640 6.39%",
"value": {
"shares": 63640,
"percentage": "6.39%"
},
"object": "e5",
"subject": "e2",
"proposed": true
},
{
"type": "share_distribution",
"quote": "Iris Belgium SRL (BCE 0540.792.024) 176.726 17,74%",
"value": {
"shares": 176726,
"percentage": "17,74%"
},
"object": "e6",
"subject": "e2",
"proposed": true
},
{
"type": "share_distribution",
"quote": "Talence SComm (BCE 0841.369.288) 86.890 8,72%",
"value": {
"shares": 86890,
"percentage": "8,72%"
},
"object": "e7",
"subject": "e2",
"proposed": true
},
{
"type": "share_distribution",
"quote": "Vinsovier Soci\u00E9t\u00E9 simple 210.832 21,16%",
"value": {
"shares": 210832,
"percentage": "21,16%"
},
"object": "e8",
"subject": "e2",
"proposed": true
},
{
"type": "share_distribution",
"quote": "CANA Soci\u00E9t\u00E9 simple 58.483 5,87%",
"value": {
"shares": 58483,
"percentage": "5,87%"
},
"object": "e9",
"subject": "e2",
"proposed": true
},
{
"type": "share_distribution",
"quote": "Monsieur Georges Guillaume 3.746 0,38%",
"value": {
"shares": 3746,
"percentage": "0,38%"
},
"object": "e10",
"subject": "e2",
"proposed": true
},
{
"type": "share_distribution",
"quote": "Monsieur Pascal Lizin 3.829 0.38%",
"value": {
"shares": 3829,
"percentage": "0.38%"
},
"object": "e11",
"subject": "e2",
"proposed": true
},
{
"type": "share_distribution",
"quote": "Nomainvest SA (BCE 0460.996.458) 252.041 25,30%",
"value": {
"shares": 252041,
"percentage": "25,30%"
},
"object": "e12",
"subject": "e2",
"proposed": true
},
{
"type": "share_distribution",
"quote": "Wallonie Entreprendre (BCE 0793.630.244) 140.081 14,06%",
"value": {
"shares": 140081,
"percentage": "14,06%"
},
"object": "e13",
"subject": "e2",
"proposed": true
},
{
"type": "accounting_effect",
"quote": "Les op\u00E9rations de la Soci\u00E9t\u00E9 \u00E0 Scinder seront, du point de vue comptable, consid\u00E9r\u00E9es comme accomplies pour compte de NOVAFORM PHARMA \u00E0 compter du 1er janvier 2026 \u00E0 0h00",
"value": "2026-01-01",
"object": null,
"subject": "e2",
"proposed": true
},
{
"type": "power_of_attorney",
"quote": "Le conseil d\u0027administration de BEPHARBEL MANUFACTRING SA donne par la pr\u00E9sente procuration \u00E0 Ma\u00EEtre Christophe Krzewinski, avocat... afin de d\u00E9poser le projet de scission et l\u0027ensemble des documents requis au greffe du Tribunal de l\u0027entreprise du Hainaut ainsi que de faire l\u0027ensemble des formalit\u00E9s n\u00E9cessaires \u00E0 la publication au Moniteur belge",
"value": {
"date": "2026-05-13",
"scope": "d\u00E9poser le projet de scission et l\u0027ensemble des documents requis au greffe du Tribunal de l\u0027entreprise du Hainaut ainsi que de faire l\u0027ensemble des formalit\u00E9s n\u00E9cessaires \u00E0 la publication au Moniteur belge"
},
"object": "e14",
"subject": "e1",
"proposed": true
},
{
"type": "power_of_attorney",
"quote": "ainsi qu\u0027\u00E0 tout autre avocat du cabinet K/Partners, avec pouvoir de substitution, afin de d\u00E9poser le projet de scission et l\u0027ensemble des documents requis au greffe du Tribunal de l\u0027entreprise du Hainaut ainsi que de faire l\u0027ensemble des formalit\u00E9s n\u00E9cessaires \u00E0 la publication au Moniteur belge",
"value": {
"date": "2026-05-13",
"scope": "d\u00E9poser le projet de scission et l\u0027ensemble des documents requis au greffe du Tribunal de l\u0027entreprise du Hainaut ainsi que de faire l\u0027ensemble des formalit\u00E9s n\u00E9cessaires \u00E0 la publication au Moniteur belge"
},
"object": "e15",
"subject": "e1",
"proposed": true
},
{
"type": "approval",
"quote": "La date ultime d\u0027approbation du pr\u00E9sent projet de scission par l\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de la soci\u00E9t\u00E9 \u00E0 Scinder \u00AB BEPHARBEL MANUFACTURING \u003E est fix\u00E9e au 15 juillet 2026.",
"value": {
"type": "assembl\u00E9e g\u00E9n\u00E9rale des actionnaires",
"deadline": "2026-07-15"
},
"object": null,
"subject": "e1",
"proposed": true
},
{
"type": "incorporation",
"quote": "La soci\u00E9t\u00E9 anonyme BePharBel Manufacturing, constitu\u00E9e suivant un acte re\u00E7u par le notaire Jean-Philippe Matagne, en date du 20 mars 2012.",
"value": {
"date": "2012-03-20",
"notary": "Jean-Philippe Matagne"
},
"object": null,
"subject": "e1",
"proposed": true
},
{
"type": "statute_amendment",
"quote": "Ses statuts ont \u00E9t\u00E9 modifi\u00E9s pour la derni\u00E8re fois en date du 5 mai 2026 suivant un acte re\u00E7u par le Notaire Edouard-Jean Navez, en cours de publication.",
"value": {
"date": "2026-05-05",
"notary": "Edouard-Jean Navez"
},
"object": null,
"subject": "e1",
"proposed": true
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 26/05/2026",
"value": "2026-05-26",
"object": null,
"subject": null
},
{
"type": "purpose",
"quote": "a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en\nBelgique et \u00E0 l\u0027\u00E9tranger, la recherche, la fabrication, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation\net l\u0027exportation, et la transformation:\n-de tous produits chimiques, pharmaceutiques, di\u00E9t\u00E9tiques, phytopharmaceutiques, hom\u00E9opathiques,\nv\u00E9t\u00E9rinaires et d\u0027herboristerie;\n-de tous articles de droguerie en g\u00E9n\u00E9ral, de parfumerie, de cosm\u00E9tiques, d\u0027hygi\u00E8ne et d\u0027entretien;\n-d\u0027accessoires m\u00E9dicaux et chirurgicaux, d\u0027acoustique, d\u0027optique, d\u0027orthop\u00E9die et de bandages; de tous\nautres produits se rapportant d\u0027une fa\u00E7on quelconque aux articles repris ci-dessus et pouvant y \u00EAtre adjoint",
"value": "tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et \u00E0 l\u0027\u00E9tranger, la recherche, la fabrication, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation et l\u0027exportation, et la transformation: -de tous produits chimiques, pharmaceutiques, di\u00E9t\u00E9tiques, phytopharmaceutiques, hom\u00E9opathiques, v\u00E9t\u00E9rinaires et d\u0027herboristerie; -de tous articles de droguerie en g\u00E9n\u00E9ral, de parfumerie, de cosm\u00E9tiques, d\u0027hygi\u00E8ne et d\u0027entretien; -d\u0027accessoires m\u00E9dicaux et chirurgicaux, d\u0027acoustique, d\u0027optique, d\u0027orthop\u00E9die et de bandages; de tous autres produits se rap",
"object": null,
"subject": null,
"proposed": true
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Projet de scission partielle par constitution d\u0027une nouvelle soci\u00E9t\u00E9",
"value": "Projet de scission partielle par constitution d\u0027une nouvelle soci\u00E9t\u00E9",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 27741,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0844.689.955",
"kind": "company",
"name": "BEPHARBEL MANUFACTURING",
"attrs": {
"seat": "Rue du Luxembourg 13, 6180 Courcelles",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": null,
"kind": "company",
"name": "NOVAFORM PHARMA",
"attrs": {
"seat": "Rue du Luxembourg 13, 6180 Courcelles",
"status": "Soci\u00E9t\u00E9 \u00E0 Constituer",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Jean-Philippe Matagne",
"attrs": {
"role": "notaire"
}
},
{
"id": "e4",
"kbo": null,
"kind": "person",
"name": "Edouard-Jean Navez",
"attrs": {
"role": "Notaire"
}
},
{
"id": "e5",
"kbo": "0884.341.575",
"kind": "company",
"name": "Sambrinvest Spin-Off/Spin-Out SA",
"attrs": {}
},
{
"id": "e6",
"kbo": "0540.792.024",
"kind": "company",
"name": "Iris Belgium SRL",
"attrs": {}
},
{
"id": "e7",
"kbo": "0841.369.288",
"kind": "company",
"name": "Talence SComm",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "company",
"name": "Vinsovier Soci\u00E9t\u00E9 simple",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "company",
"name": "CANA Soci\u00E9t\u00E9 simple",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Georges Guillaume",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Pascal Lizin",
"attrs": {}
},
{
"id": "e12",
"kbo": "0460.996.458",
"kind": "company",
"name": "Nomainvest SA",
"attrs": {}
},
{
"id": "e13",
"kbo": "0793.630.244",
"kind": "company",
"name": "Wallonie Entreprendre",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Christophe Krzewinski",
"attrs": {
"role": "avocat"
}
},
{
"id": "e15",
"kbo": null,
"kind": "org",
"name": "K/Partners",
"attrs": {
"type": "cabinet d\u0027avocats"
}
},
{
"id": "e16",
"kbo": null,
"kind": "person",
"name": "Vincent STEPHENNE",
"attrs": {
"role": "Administrateur d\u00E9l\u00E9gu\u00E9"
}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Bernard Jolly",
"attrs": {
"role": "Pr\u00E9sident du Conseil d\u0027Administration"
}
}
]
}18-08-2025 3 directors appointed
- Yves Noël, Président du conseil d'administration
- Bernard Jolly, Gedelegeerd bestuurder
- Maxime Wayoff
Technical details
{
"events": [
{
"kind": "director_in",
"role": "pr\u00E9sident du Conseil d\u0027Administration",
"person": {
"rrn": null,
"name": "Yves No\u00EBl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bernard Jolly",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "",
"person": {
"rrn": null,
"name": "Maxime Wayoff",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}27-02-2025 Act object · Merger · Purpose · Share issue
- Act object: Fusion par absorption de la SA BePharBel · BePharBel Manufacturing SA
- Publication: 27/02/2025 · BePharBel Manufacturing SA
- Filing: 19/02/2025 · BePharBel Manufacturing SA
- Merger · BePharBel Manufacturing SA
- Purpose: La société a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et à l'étranger, la recherche, la fabrication, l'industrie, l'achat, la vente, le conditionnement, l'importation et l'exportation, et la transformation: -de tous produits chimiques, pharmaceutiques, diététiques, phytopharmaceutiques, homéopathiques, vétérinaires et d'herboristerie; -de tous articles de droguerie en général, de parfumerie, de cosmétiques, d'hygiène et d'entretien; -d'accessoires médicaux et chirurgicaux, d'acoustique, d'optique, d'orthopédie et de bandages; de tous autres produits se rapportant d'une façon quelconque aux articles repris ci-dessus et pouvant y être adjoints utilement; -Le développement, l'exploitation et la commercialisation d'équipements et d'accessoires relatifs aux activités de recherche, développement, production et commercialisation des produits et articles repris ci-dessus -La vente de tous livres ou supports papier ou électronique en rapport avec son objet; et en général toutes activités intéressant l'approvisionnement de l'industrie chimique, des hôpitaux et cliniques, des officines pharmaceutiques et drogueries ainsi que des matières et produits similaires et connexes. La société peut de manière générale, entreprendre toutes opérations de commerce, d'industrie et de finance, mobilières et immobilières, dans toutes entreprises dont l'objet se rattache directement ou indirectement à son industrie ou son commerce/ en tout ou en partie à son objet ou qui seraient de nature à en faciliter ou à développer la réalisation/ La société peut également exercer toute activité d'ingénieur conseil, de bureau d'études, de conception ou réalisation d'appareils ou d'entreprises publique ou privée- y compris l'organisation- rien excepté ni réservé. La société peut s'intéresser par voie d'apport, de fusion, de souscription, d'association, de cession, ou achat de titres ou droits sociaux, ou de toute autre manière dans toutes sociétés, entreprises ou associations existantes ou à créer en Belgique ou à l'étranger, dont l'objet se rattache directement ou indirectement à son industrie ou son commerce/ à son objet ou simplement susceptible d'accroitre son activité sociale. La société pourra acquérir, exploiter et céder des brevets ou licences ayant trait, directement ou indirectement, aux opérations se rapportant à l'objet. Cette énumération est simplement énonciative et nullement limitative. · BePharBel Manufacturing SA
- Purpose: La société a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et à l'étranger, la recherche, la fabrication, l'industrie, l'achat, la vente, le conditionnement, l'importation et l'exportation, et la transformation : -de tous produits chimiques, pharmaceutiques, diététiques, phytopharmaceutiques, homéopathiques, vétérinaires et d'herboristerie: -de tous articles de droguerie en général, de parfumerie, de cosmétiques, d'hygiène et d'entretien; -d'accessoires médicaux et chirurgicaux, d'acoustique, d'optique, d'orthopédie et de bandages; de tous autres produits se rapportant d'une façon quelconque aux articles repris ci-dessus et pouvant y être adjoints utilement: -Le développement, l'exploitation et la commercialisation d'équipements et d'accessoires relatifs aux activités de recherche, développement, production et commercialisation des produits et articles repris ci-dessus - La vente de tous livres ou supports papier ou électronique en rapport avec son objet; et en général toutes activités intéressant l'approvisionnement de l'industrie chimique, des hôpitaux et cliniques, des officines pharmaceutiques et drogueries ainsi que des matières et produits similaires et connexes. La société peut de manière générale, entreprendre toutes opérations de commerce, d'industrie et de finance, mobilières et immobilières, dans toutes entreprises dont l'objet se rattache directement ou indirectement à son industrie ou son commerce, en tout ou en partie à son objet ou qui seraient de nature à en faciliter ou à développer la réalisation. La société peut également exercer toute activité d'ingénieur conseil, de bureau d'études, de conception ou réalisation d'appareils ou d'entreprises publique ou privée - y compris l'organisation - rien excepté ni réservé. La société peut s'intéresser par voie d'apport, de fusion, de souscription, d'association, de cession, ou achat de titres ou droits sociaux, ou de toute autre manière dans toutes sociétés, entreprises ou associations existantes ou à créer en Belgique ou à l'étranger, dont l'objet se rattache directement ou indirectement à son industrie ou son commerce, à son objet ou simplement susceptible d'accroitre son activité sociale. La société pourra acquérir, exploiter et céder des brevets ou licences ayant trait, directement ou indirectement, aux opérations se rapportant à l'objet. Cette énumération est simplement énonciative et nullement limitative · BePharBel SA
- Share issue: count: 87928, reason: fusion · BePharBel Manufacturing SA
- Share cancellation: count: 87928, reason: actions propres acquises suite à la fusion · BePharBel Manufacturing SA
- Capital decrease: amount: 1206755, reason: destruction des actions propres, currency: EUR · BePharBel Manufacturing SA
- Accounting effect: 01/01/2025 · BePharBel Manufacturing SA
- Auditor appointment: role: commissaire pour rapport augmentation capital par apport en nature · Deloitte Réviseurs d'Entreprises SRL
- Filing representative · Thibault Neuzy
Technical details
{
"facts": [
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Fusion par absorption de la SA BePharBel",
"value": "Fusion par absorption de la SA BePharBel",
"object": null,
"subject": "e1"
},
{
"date": "2025-02-27",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 27/02/2025 - Annexes du Moniteur belge",
"value": "27/02/2025",
"object": null,
"subject": "e1"
},
{
"date": "2025-02-19",
"type": "filing",
"quote": "19 FEV. 2025",
"value": "19/02/2025",
"object": null,
"subject": "e1"
},
{
"type": "merger",
"quote": "Extrait du projet de fusion \u00E9tabli conjointement par le Conseil d\u0027administration de BePharBel SA et de BePharBel Manufacturing SA",
"value": {
"proposed": true
},
"object": "e2",
"status": "proposed",
"subject": "e1"
},
{
"type": "purpose",
"quote": "Son objet social est le suivant: ...",
"value": "La soci\u00E9t\u00E9 a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et \u00E0 l\u0027\u00E9tranger, la recherche, la fabrication, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation et l\u0027exportation, et la transformation: -de tous produits chimiques, pharmaceutiques, di\u00E9t\u00E9tiques, phytopharmaceutiques, hom\u00E9opathiques, v\u00E9t\u00E9rinaires et d\u0027herboristerie; -de tous articles de droguerie en g\u00E9n\u00E9ral, de parfumerie, de cosm\u00E9tiques, d\u0027hygi\u00E8ne et d\u0027entretien; -d\u0027accessoires m\u00E9dicaux et chirurgicaux, d\u0027acoustique, d\u0027optique, d\u0027orthop\u00E9die et de bandages; de tous autres produits se rapportant d\u0027une fa\u00E7on quelconque aux articles repris ci-dessus et pouvant y \u00EAtre adjoints utilement; -Le d\u00E9veloppement, l\u0027exploitation et la commercialisation d\u0027\u00E9quipements et d\u0027accessoires relatifs aux activit\u00E9s de recherche, d\u00E9veloppement, production et commercialisation des produits et articles repris ci-dessus -La vente de tous livres ou supports papier ou \u00E9lectronique en rapport avec son objet; et en g\u00E9n\u00E9ral toutes activit\u00E9s int\u00E9ressant l\u0027approvisionnement de l\u0027industrie chimique, des h\u00F4pitaux et cliniques, des officines pharmaceutiques et drogueries ainsi que des mati\u00E8res et produits similaires et connexes. La soci\u00E9t\u00E9 peut de mani\u00E8re g\u00E9n\u00E9rale, entreprendre toutes op\u00E9rations de commerce, d\u0027industrie et de finance, mobili\u00E8res et immobili\u00E8res, dans toutes entreprises dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce/ en tout ou en partie \u00E0 son objet ou qui seraient de nature \u00E0 en faciliter ou \u00E0 d\u00E9velopper la r\u00E9alisation/ La soci\u00E9t\u00E9 peut \u00E9galement exercer toute activit\u00E9 d\u0027ing\u00E9nieur conseil, de bureau d\u0027\u00E9tudes, de conception ou r\u00E9alisation d\u0027appareils ou d\u0027entreprises publique ou priv\u00E9e- y compris l\u0027organisation- rien except\u00E9 ni r\u00E9serv\u00E9. La soci\u00E9t\u00E9 peut s\u0027int\u00E9resser par voie d\u0027apport, de fusion, de souscription, d\u0027association, de cession, ou achat de titres ou droits sociaux, ou de toute autre mani\u00E8re dans toutes soci\u00E9t\u00E9s, entreprises ou associations existantes ou \u00E0 cr\u00E9er en Belgique ou \u00E0 l\u0027\u00E9tranger, dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce/ \u00E0 son objet ou simplement susceptible d\u0027accroitre son activit\u00E9 sociale. La soci\u00E9t\u00E9 pourra acqu\u00E9rir, exploiter et c\u00E9der des brevets ou licences ayant trait, directement ou indirectement, aux op\u00E9rations se rapportant \u00E0 l\u0027objet. Cette \u00E9num\u00E9ration est simplement \u00E9nonciative et nullement limitative.",
"object": null,
"subject": "e1"
},
{
"type": "purpose",
"quote": "Son objet social est le suivant : ...",
"value": "La soci\u00E9t\u00E9 a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et \u00E0 l\u0027\u00E9tranger, la recherche, la fabrication, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation et l\u0027exportation, et la transformation : -de tous produits chimiques, pharmaceutiques, di\u00E9t\u00E9tiques, phytopharmaceutiques, hom\u00E9opathiques, v\u00E9t\u00E9rinaires et d\u0027herboristerie: -de tous articles de droguerie en g\u00E9n\u00E9ral, de parfumerie, de cosm\u00E9tiques, d\u0027hygi\u00E8ne et d\u0027entretien; -d\u0027accessoires m\u00E9dicaux et chirurgicaux, d\u0027acoustique, d\u0027optique, d\u0027orthop\u00E9die et de bandages; de tous autres produits se rapportant d\u0027une fa\u00E7on quelconque aux articles repris ci-dessus et pouvant y \u00EAtre adjoints utilement: -Le d\u00E9veloppement, l\u0027exploitation et la commercialisation d\u0027\u00E9quipements et d\u0027accessoires relatifs aux activit\u00E9s de recherche, d\u00E9veloppement, production et commercialisation des produits et articles repris ci-dessus - La vente de tous livres ou supports papier ou \u00E9lectronique en rapport avec son objet; et en g\u00E9n\u00E9ral toutes activit\u00E9s int\u00E9ressant l\u0027approvisionnement de l\u0027industrie chimique, des h\u00F4pitaux et cliniques, des officines pharmaceutiques et drogueries ainsi que des mati\u00E8res et produits similaires et connexes. La soci\u00E9t\u00E9 peut de mani\u00E8re g\u00E9n\u00E9rale, entreprendre toutes op\u00E9rations de commerce, d\u0027industrie et de finance, mobili\u00E8res et immobili\u00E8res, dans toutes entreprises dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce, en tout ou en partie \u00E0 son objet ou qui seraient de nature \u00E0 en faciliter ou \u00E0 d\u00E9velopper la r\u00E9alisation. La soci\u00E9t\u00E9 peut \u00E9galement exercer toute activit\u00E9 d\u0027ing\u00E9nieur conseil, de bureau d\u0027\u00E9tudes, de conception ou r\u00E9alisation d\u0027appareils ou d\u0027entreprises publique ou priv\u00E9e - y compris l\u0027organisation - rien except\u00E9 ni r\u00E9serv\u00E9. La soci\u00E9t\u00E9 peut s\u0027int\u00E9resser par voie d\u0027apport, de fusion, de souscription, d\u0027association, de cession, ou achat de titres ou droits sociaux, ou de toute autre mani\u00E8re dans toutes soci\u00E9t\u00E9s, entreprises ou associations existantes ou \u00E0 cr\u00E9er en Belgique ou \u00E0 l\u0027\u00E9tranger, dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce, \u00E0 son objet ou simplement susceptible d\u0027accroitre son activit\u00E9 sociale. La soci\u00E9t\u00E9 pourra acqu\u00E9rir, exploiter et c\u00E9der des brevets ou licences ayant trait, directement ou indirectement, aux op\u00E9rations se rapportant \u00E0 l\u0027objet. Cette \u00E9num\u00E9ration est simplement \u00E9nonciative et nullement limitative",
"object": null,
"subject": "e2"
},
{
"type": "share_issue",
"quote": "la Soci\u00E9t\u00E9 Absorbante \u00E9mettra 87.928 actions nouvelles",
"value": {
"count": 87928,
"reason": "fusion"
},
"object": null,
"subject": "e1"
},
{
"type": "share_cancellation",
"quote": "proposer \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de d\u00E9cider imm\u00E9diatement apr\u00E8s la Fusion de d\u00E9truire ces 87.928 actions propres",
"value": {
"count": 87928,
"reason": "actions propres acquises suite \u00E0 la fusion"
},
"object": null,
"subject": "e1"
},
{
"type": "capital_decrease",
"quote": "r\u00E9duire les fonds propres de la Soci\u00E9t\u00E9 Absorbante en cons\u00E9quence. Cette r\u00E9duction des fonds propres correspondra au montant \u00E9quivalent \u00E0 la valeur de la participation dans la Soci\u00E9t\u00E9 Absorbante reprises dans le bilan de la Soci\u00E9t\u00E9 Absorb\u00E9e au 31 d\u00E9cembre 2024 sous la rubrique \u003C immobilisations financi\u00E8res \u00BB\u003E, \u00E0 savoir: 1.206.755 \u20AC.",
"value": {
"amount": 1206755,
"reason": "destruction des actions propres",
"currency": "EUR"
},
"amount": 1206755.0,
"object": null,
"subject": "e1",
"currency": "EUR"
},
{
"date": "2025-01-01",
"type": "accounting_effect",
"quote": "La Fusion prendra effet le 1er janvier 2025 \u00E0 0.00 heure. Les op\u00E9rations de la Soci\u00E9t\u00E9 Absorb\u00E9e seront consid\u00E9r\u00E9es du point de vue comptable comme accomplies pour le compte de la Soci\u00E9t\u00E9 Absorbante \u00E0 partir de cette date.",
"value": "01/01/2025",
"object": null,
"subject": "e1"
},
{
"type": "auditor_appointment",
"quote": "Le rapport relatif \u00E0 l\u0027augmentation du capital par apport en nature sera \u00E9tabli, conform\u00E9ment aux articles 7:179 et 7:197 du CSA, par le commissaire des deux Soci\u00E9t\u00E9s: Deloitte R\u00E9viseurs d\u0027Entreprises SRL, repr\u00E9sent\u00E9e par Julie Delforge.",
"value": {
"role": "commissaire pour rapport augmentation capital par apport en nature"
},
"object": "e1",
"subject": "e13"
},
{
"type": "filing_representative",
"quote": "Pour copie conforme Thibault Neuzy Mandataire",
"value": null,
"object": "e1",
"subject": "e15"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 15127,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0844.689.955",
"kind": "company",
"name": "BePharBel Manufacturing SA",
"attrs": {
"seat": "Rue du Luxembourg, 13 \u00E0 6180 Courcelles",
"legal_form": "soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": "0843.905.938",
"kind": "company",
"name": "BePharBel SA",
"attrs": {
"seat": "Rue du Luxembourg, 13 \u00E0 6180 Courcelles",
"legal_form": "soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e3",
"kbo": "0884.341.575",
"kind": "company",
"name": "Sambrinvest Spin-Off/Spin-Out SA",
"attrs": {}
},
{
"id": "e4",
"kbo": "0540.792.024",
"kind": "company",
"name": "Iris Belgium SRL",
"attrs": {}
},
{
"id": "e5",
"kbo": "0841.369.288",
"kind": "company",
"name": "Talence SComm",
"attrs": {}
},
{
"id": "e6",
"kbo": null,
"kind": "company",
"name": "Vinsovier Soci\u00E9t\u00E9 simple",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "company",
"name": "CANA Soci\u00E9t\u00E9 simple",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Georges Guillaume",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Pascal Lizin",
"attrs": {}
},
{
"id": "e10",
"kbo": "0460.996.458",
"kind": "company",
"name": "Nomainvest SA",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Vincent St\u00E9phenne",
"attrs": {}
},
{
"id": "e12",
"kbo": "0793.630.244",
"kind": "company",
"name": "Wallonie Entreprendre",
"attrs": {}
},
{
"id": "e13",
"kbo": null,
"kind": "company",
"name": "Deloitte R\u00E9viseurs d\u0027Entreprises SRL",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Julie Delforge",
"attrs": {}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Thibault Neuzy",
"attrs": {}
}
]
}28-06-2024 Wilfried Schöpges appointed as director
- Wilfried Schöpges, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Wilfried Sch\u00F6pges",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}07-11-2022 3 directors appointed, 3 resigning
- Carl Laschet, Representant permanent du commissaire de la société
- Cheniclem s.a., Bestuurder
- Cheniclem s.a., Gedelegeerd bestuurder
- Laurent Weerts, Representant permanent du commissaire de la société
- M. Bernard Jolly, Bestuurder
- M. Bernard Jolly, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "representant permanent du commissaire de la Soci\u00E9t\u00E9",
"person": {
"rrn": null,
"name": "Carl Laschet",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "representant permanent du commissaire de la Soci\u00E9t\u00E9",
"person": {
"rrn": null,
"name": "Laurent Weerts",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "M. Bernard Jolly",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "M. Bernard Jolly",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Cheniclem s.a.",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Cheniclem s.a.",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}14-07-2022 Capital increase of €22,555,624.00 to €47,868,985.91
- €25.313.361,91 → €47.868.985,91
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 47868985.91,
"delta_eur": 22555623.999999996,
"before_eur": 25313361.91,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}10-06-2022 3 directors appointed
- Bernard Jolly, Bestuurder
- Yves Noëi, Bestuurder
- Bernard Jolly, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bernard Jolly",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0828.125.622",
"name": "Cheniclem Private Equity s.a.",
"address": null,
"country": "BE",
"legal_form": "s.a."
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Cheniclem Private Equity s.a. (BCE 0828.125.622) est nomm\u00E9e administratrice pour une dur\u00E9e de trois ans jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui approuvera les comptes annuels 2024. Elle sera repr\u00E9sent\u00E9e de fa\u00E7on permanente par Monsieur Bernard Jolly.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "3"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Yves No\u00EBi",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0451.640.611",
"name": "No\u00EBl Management \u0026 Finance s.a.",
"address": null,
"country": "BE",
"legal_form": "s.a."
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "No\u00EBl Management \u0026 Finance s.a. (BCE 0451.640.611) est nomm\u00E9e administratrice pour une dur\u00E9e trois ans jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui approuvera les comptes annuels 2024. Elle sera repr\u00E9sent\u00E9e de fa\u00E7on permanente par Monsieur Yves No\u00EBi.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "3"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bernard Jolly",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0828.125.622",
"name": "Cheniciem Private Equity s.a.",
"address": null,
"country": "BE",
"legal_form": "s.a."
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Cheniciem Private Equity s.a. (BCE 0828.125.622) est nomm\u00E9e administrateur d\u00E9l\u00E9gu\u00E9 pour une dur\u00E9e de trois ans jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui approuvera les comptes annuels 2024. Elle sera repr\u00E9sent\u00E9e de fa\u00E7on permanente par Monsieur Bernard Jolly.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "3"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2022-06-10",
"filing_date": "2022-05-06",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2022-05-06",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST",
"legal_form": "SA",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}07-07-2021 Act object · General meeting · Officer appointment
- Publication: 07/07/2021 · NANOCYL
- Filing: 29/06/2021 · NANOCYL
- Act object: Modification du Conseil d'Administration · NANOCYL
- General meeting: 20/04/2021 · NANOCYL
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Innoste
- Officer appointment: role: président du Conseil d'Administration, term: 4 ans, start_date: 2021-04-20 · Jean Stephenne
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Nomainvest
- Officer appointment: role: représentant, term: 4 ans, start_date: 2021-04-20 · Yves Noël
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Mitiska
- Officer appointment: role: représentant, term: 4 ans, start_date: 2021-04-20 · Bernard Raevens
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Samanda
- Officer appointment: role: représentant, term: 4 ans, start_date: 2021-04-20 · Adrien Grabarski
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · SFPI
- Officer appointment: role: représentant, term: 4 ans, start_date: 2021-04-20 · Matthieu de Posch
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Franfin
- Officer appointment: role: représentant, term: 4 ans, start_date: 2021-04-20 · Baudouin Dubuisson
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Compagnie du Bois Sauvage
- Officer appointment: role: représentant, term: 4 ans, start_date: 2021-04-20 · Benoit Deckers
- Officer appointment: role: administrateur indépendant, term: 4 ans, start_date: 2021-04-20 · Arpego
- Officer appointment: role: représentant, term: 4 ans, start_date: 2021-04-20 · Pierre Joris
- Officer appointment: role: Administrateur délégué, term: 4 ans, start_date: 2021-04-20 · Laurent Kosbach
Technical details
{
"facts": [
{
"date": "2021-07-07",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 07/07/2021",
"value": "07/07/2021",
"object": null,
"subject": "e1"
},
{
"date": "2021-06-29",
"type": "filing",
"quote": "D\u00E9pos\u00E9 au Greffe du Tribunal de l\u0027entreprise de Li\u00E8ge division Namur 29 JUIN 2021",
"value": "29/06/2021",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet de l\u0027acte: Modification du Conseil d\u0027Administration",
"value": "Modification du Conseil d\u0027Administration",
"object": null,
"subject": "e1"
},
{
"date": "2021-04-20",
"type": "general_meeting",
"quote": "PROCES-VERBAL DE L\u0027ASSEMBLEE GENERALE ORDINAIRE DU 20/04/2021",
"value": "20/04/2021",
"object": null,
"subject": "e1"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "A dater du 20/04/2021, le Conseil d\u0027Administration de Nanocyl, \u00E9lu pour 4 ans, se compose de: - La soci\u00E9t\u00E9 Innoste",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 Innoste ... repr\u00E9sent\u00E9e par Mr. Jean Stephenne, pr\u00E9sident du Conseil d\u0027Administration",
"value": {
"role": "pr\u00E9sident du Conseil d\u0027Administration",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "pr\u00E9sident du Conseil d\u0027Administration",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La soci\u00E9t\u00E9 Nomainvest",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 Nomainvest ... repr\u00E9sent\u00E9e par Mr. Yves No\u00EBl",
"value": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e5",
"_value_raw": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "-La soci\u00E9t\u00E9 Mitiska",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e6",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 Mitiska ... repr\u00E9sent\u00E9e Mr. Bernard Raevens",
"value": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e7",
"_value_raw": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La soci\u00E9t\u00E9 Samanda",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e8",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 Samanda ... repr\u00E9sent\u00E9e par MMr. Adrien Grabarski",
"value": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e9",
"_value_raw": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La SFPI",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e10",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "La SFPI ... repr\u00E9sent\u00E9e par Mr. Matthieu de Posch",
"value": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e11",
"_value_raw": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La soci\u00E9t\u00E9 Franfin",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e12",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 Franfin ... repr\u00E9sent\u00E9e par Mr. Baudouin Dubuisson",
"value": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e13",
"_value_raw": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La soci\u00E9t\u00E9 Compagnie du Bois Sauvage",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e14",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 Compagnie du Bois Sauvage ... repr\u00E9sent\u00E9e par Mr. Benoit Deckers",
"value": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e15",
"_value_raw": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La soci\u00E9t\u00E9 Arpego ... (administrateur ind\u00E9pendant)",
"value": {
"role": "administrateur ind\u00E9pendant",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e16",
"_value_raw": {
"role": "administrateur ind\u00E9pendant",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 Arpego ... repr\u00E9sent\u00E9e par Mr. Pierre Joris",
"value": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e17",
"_value_raw": {
"role": "repr\u00E9sentant",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "Administrateur d\u00E9l\u00E9gu\u00E9: Mr. Laurent Kosbach.",
"value": {
"role": "Administrateur d\u00E9l\u00E9gu\u00E9",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e18",
"_value_raw": {
"role": "Administrateur d\u00E9l\u00E9gu\u00E9",
"term": "4 ans",
"start_date": "20/04/2021"
}
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1925,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0476.998.785",
"kind": "company",
"name": "NANOCYL",
"attrs": {
"legal_form": "SA"
}
},
{
"id": "e2",
"kbo": "0876.616.318",
"kind": "company",
"name": "Innoste",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Jean Stephenne",
"attrs": {}
},
{
"id": "e4",
"kbo": "0460.996.458",
"kind": "company",
"name": "Nomainvest",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Yves No\u00EBl",
"attrs": {}
},
{
"id": "e6",
"kbo": "0465.509.730",
"kind": "company",
"name": "Mitiska",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Bernard Raevens",
"attrs": {}
},
{
"id": "e8",
"kbo": "0480.028.848",
"kind": "company",
"name": "Samanda",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "Adrien Grabarski",
"attrs": {}
},
{
"id": "e10",
"kbo": "0253.445.063",
"kind": "company",
"name": "SFPI",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Matthieu de Posch",
"attrs": {}
},
{
"id": "e12",
"kbo": "0466.136.567",
"kind": "company",
"name": "Franfin",
"attrs": {}
},
{
"id": "e13",
"kbo": null,
"kind": "person",
"name": "Baudouin Dubuisson",
"attrs": {}
},
{
"id": "e14",
"kbo": "0402.964.823",
"kind": "company",
"name": "Compagnie du Bois Sauvage",
"attrs": {}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Benoit Deckers",
"attrs": {}
},
{
"id": "e16",
"kbo": "0539.765.507",
"kind": "company",
"name": "Arpego",
"attrs": {}
},
{
"id": "e17",
"kbo": null,
"kind": "person",
"name": "Pierre Joris",
"attrs": {}
},
{
"id": "e18",
"kbo": null,
"kind": "person",
"name": "Laurent Kosbach",
"attrs": {}
}
]
}16-06-2021 General meeting · Officer appointment · Permanent representative
- Publication: 16/06/2021 · NANOCYL
- Filing: 07/06/2021 · NANOCYL
- General meeting: 20/04/2021 · NANOCYL
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Innoste
- Permanent representative · Jean Stephenne
- Officer appointment: role: président du Conseil d'Administration, term: 4 ans, start_date: 2021-04-20 · Jean Stephenne
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Nomainvest
- Permanent representative · Yves Noël
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Mitiska
- Permanent representative · Onalim SPRL
- Permanent representative · Bernard Raevens
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Samanda
- Permanent representative · Adrien Grabarski
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · SFPI
- Permanent representative · Matthieu de Posch
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Franfin
- Permanent representative · Baudouin Dubuisson
- Officer appointment: role: administrateur, term: 4 ans, start_date: 2021-04-20 · Compagnie du Bois Sauvage
- Permanent representative · Benoit Deckers
- Officer appointment: role: administrateur indépendant, term: 4 ans, start_date: 2021-04-20 · Arpego
- Permanent representative · Pierre Joris
- Officer appointment: role: Administrateur délégué, term: 4 ans, start_date: 2021-04-20 · Laurent Kosbach
Technical details
{
"facts": [
{
"date": "2021-06-16",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 16/06/2021",
"value": "16/06/2021",
"object": null,
"subject": "e1"
},
{
"date": "2021-06-07",
"type": "filing",
"quote": "D\u00E9pos\u00E9 au Greffo du Tribunal de l\u0027entreprise de Li\u00E8ge division Namur 07 JUIN 2021",
"value": "07/06/2021",
"object": null,
"subject": "e1"
},
{
"date": "2021-04-20",
"type": "general_meeting",
"quote": "PROCES-VERBAL DE L\u0027ASSEMBLEE GENERALE ORDINAIRE DU 20/04/2021",
"value": "20/04/2021",
"object": null,
"subject": "e1"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "A dater du 20/04/2021, le Conseil d\u0027Administration de Nanocyl, \u00E9lu pour 4 ans, se compose de: - La soci\u00E9t\u00E9 Innoste",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 Innoste ... repr\u00E9sent\u00E9e par Mr. Jean Stephenne",
"value": null,
"object": "e2",
"subject": "e3"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "Mr. Jean Stephenne, pr\u00E9sident du Conseil d\u0027Administration",
"value": {
"role": "pr\u00E9sident du Conseil d\u0027Administration",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "pr\u00E9sident du Conseil d\u0027Administration",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La soci\u00E9t\u00E9 Nomainvest",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 Nomainvest ... repr\u00E9sent\u00E9e par Mr. Yves No\u00EBl",
"value": null,
"object": "e4",
"subject": "e5"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "-La soci\u00E9t\u00E9 Mitiska",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e6",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 Mitiska ... repr\u00E9sent\u00E9e par Onalim SPRL",
"value": null,
"object": "e6",
"subject": "e7"
},
{
"type": "permanent_representative",
"quote": "Onalim SPRL ... repr\u00E9sent\u00E9e Mr. Bernard Raevens",
"value": null,
"object": "e7",
"subject": "e8"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "-La soci\u00E9t\u00E9 Samanda",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e9",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 Samanda ... repr\u00E9sent\u00E9e par Mr. Adrien Grabarski",
"value": null,
"object": "e9",
"subject": "e10"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La SFPI",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e11",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"type": "permanent_representative",
"quote": "La SFPI ... repr\u00E9sent\u00E9e par Mr. Matthieu de Posch",
"value": null,
"object": "e11",
"subject": "e12"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La soci\u00E9t\u00E9 Franfin",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e13",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 Franfin ... repr\u00E9sent\u00E9e par Mr. Baudouin Dubuisson",
"value": null,
"object": "e13",
"subject": "e14"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- La soci\u00E9t\u00E9 Compagnie du Bois Sauvage",
"value": {
"role": "administrateur",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e15",
"_value_raw": {
"role": "administrateur",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 Compagnie du Bois Sauvage ... repr\u00E9sent\u00E9e par Mr. Benoit Deckers",
"value": null,
"object": "e15",
"subject": "e16"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "-La soci\u00E9t\u00E9 Arpego ... repr\u00E9sent\u00E9e par Mr. Pierre Joris (administrateur ind\u00E9pendant)",
"value": {
"role": "administrateur ind\u00E9pendant",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e17",
"_value_raw": {
"role": "administrateur ind\u00E9pendant",
"term": "4 ans",
"start_date": "20/04/2021"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 Arpego ... repr\u00E9sent\u00E9e par Mr. Pierre Joris",
"value": null,
"object": "e17",
"subject": "e18"
},
{
"date": "2021-04-20",
"type": "officer_appointment",
"quote": "- Administrateur d\u00E9l\u00E9gu\u00E9: Mr. Laurent Kosbach.",
"value": {
"role": "Administrateur d\u00E9l\u00E9gu\u00E9",
"term": "4 ans",
"start_date": "2021-04-20"
},
"object": null,
"subject": "e19",
"_value_raw": {
"role": "Administrateur d\u00E9l\u00E9gu\u00E9",
"term": "4 ans",
"start_date": "20/04/2021"
}
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 2000,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0476.998.785",
"kind": "company",
"name": "NANOCYL",
"attrs": {
"seat": "Rue de l\u0027Essor, 4 \u00E0 5060 Sambreville",
"legal_form": "SA"
}
},
{
"id": "e2",
"kbo": "0876.616.318",
"kind": "company",
"name": "Innoste",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Jean Stephenne",
"attrs": {}
},
{
"id": "e4",
"kbo": "0460.996.458",
"kind": "company",
"name": "Nomainvest",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Yves No\u00EBl",
"attrs": {}
},
{
"id": "e6",
"kbo": "0465.509.730",
"kind": "company",
"name": "Mitiska",
"attrs": {}
},
{
"id": "e7",
"kbo": "0826.735.750",
"kind": "company",
"name": "Onalim SPRL",
"attrs": {}
},
{
"id": "e8",
"kbo": null,
"kind": "person",
"name": "Bernard Raevens",
"attrs": {}
},
{
"id": "e9",
"kbo": "0480.028.848",
"kind": "company",
"name": "Samanda",
"attrs": {}
},
{
"id": "e10",
"kbo": null,
"kind": "person",
"name": "Adrien Grabarski",
"attrs": {}
},
{
"id": "e11",
"kbo": "0253.445.063",
"kind": "company",
"name": "SFPI",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Matthieu de Posch",
"attrs": {}
},
{
"id": "e13",
"kbo": "0466.136.567",
"kind": "company",
"name": "Franfin",
"attrs": {}
},
{
"id": "e14",
"kbo": null,
"kind": "person",
"name": "Baudouin Dubuisson",
"attrs": {}
},
{
"id": "e15",
"kbo": "0402.964.823",
"kind": "company",
"name": "Compagnie du Bois Sauvage",
"attrs": {}
},
{
"id": "e16",
"kbo": null,
"kind": "person",
"name": "Benoit Deckers",
"attrs": {}
},
{
"id": "e17",
"kbo": "0539.765.507",
"kind": "company",
"name": "Arpego",
"attrs": {}
},
{
"id": "e18",
"kbo": null,
"kind": "person",
"name": "Pierre Joris",
"attrs": {}
},
{
"id": "e19",
"kbo": null,
"kind": "person",
"name": "Laurent Kosbach",
"attrs": {}
}
]
}09-06-2021 3 directors appointed, 1 resigning
- Liclem srl, Bestuurder
- Vincent Doumier srl, Bestuurder
- Good45 srl, Bestuurder
- Catherine Noël, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Catherine No\u00EBl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administratrice",
"person": {
"rrn": null,
"name": "Liclem srl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administratrice",
"person": {
"rrn": null,
"name": "Vincent Doumier srl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administratrice",
"person": {
"rrn": null,
"name": "Good45 srl",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}29-01-2021 2 directors appointed
- Yves Noël, President du conseil d'administration
- Bernard Jolly, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "president du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "Yves No\u00EBl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Bernard Jolly",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}09-06-2020 4 directors appointed
- Yves Noël, Gedelegeerd bestuurder
- Alexandre Jortay, Bestuurder
- Catherine Noël, Bestuurder
- Laurent Weerts, Bedrijfsrevisor
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur-d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Yves No\u00EBl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Alexandre Jortay",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Catherine No\u00EBl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "r\u00E9viseur",
"person": {
"rrn": null,
"name": "Laurent Weerts",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}07-06-2019 4 directors appointed
- Bernard Jolly, Administrator
- Yves Noël, Administrator
- Vincent Doumier, Administrator
- Pierre-Paul De Schrevel, Administrator
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrator",
"person": {
"rrn": null,
"name": "Bernard Jolly",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrator",
"person": {
"rrn": null,
"name": "Yves No\u00EBl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrator",
"person": {
"rrn": null,
"name": "Vincent Doumier",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrator",
"person": {
"rrn": null,
"name": "Pierre-Paul De Schrevel",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}23-07-2018 3 directors appointed, 1 resigning
- Catherine Noël, Bestuurder
- Pierre-Paul De Schrevel, Bestuurder
- Vincent Doumier, Bestuurder
- Baudouin Michiels, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Catherine No\u00EBl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Pierre-Paul De Schrevel",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Vincent Doumier",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Baudouin Michiels",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}11-10-2017 Deloitte Réviseurs d'entreprises Sc Scrl appointed as auditor
- Deloitte Réviseurs d'entreprises Sc Scrl, Auditor
Technical details
{
"events": [
{
"kind": "director_in",
"role": "auditor",
"person": {
"rrn": null,
"name": "Deloitte R\u00E9viseurs d\u0027entreprises Sc Scrl",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}26-07-2016 2 directors appointed, 1 resigning
- Nopawa s.p.r.l. représentée par good45 s.p.r.l., elle-même représentée par M. Pierre-Paul de Schrevel, Bestuurder
- M. Baudouin Michiels, Bestuurder
- Nopawa s.p.r.l. représentée par Madame Dominique Noël, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Nopawa s.p.r.l. repr\u00E9sent\u00E9e par Madame Dominique No\u00EBl",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Nopawa s.p.r.l. repr\u00E9sent\u00E9e par good45 s.p.r.l., elle-m\u00EAme repr\u00E9sent\u00E9e par M. Pierre-Paul de Schrevel",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "M. Baudouin Michiels",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST"
}
}07-09-2015 Act object · General meeting · Officer appointment · Permanent representative
- Publication: 07/09/2015 · NANOCYL
- Filing: 27/08/2015 · NANOCYL
- Act object: Confirmation du conseil d'administration · NANOCYL
- General meeting: 21/04/2015 · NANOCYL
- Officer appointment: role: administrateur, term: 6 ans, start_date: 2015-04-21 · INNOSTE
- Officer appointment: role: président du Conseil d'Administration, term: 6 ans, start_date: 2015-04-21 · Jean Stephenne
- Permanent representative · Jean Stephenne
- Officer appointment: role: administrateur, term: 6 ans, start_date: 2015-04-21 · SAMANDA SA
- Permanent representative · Christian Colson
- Officer appointment: role: administrateur, term: 6 ans, start_date: 2015-04-21 · NOMAINVEST
- Permanent representative · Yves Noël
- Officer appointment: role: administrateur, term: 6 ans, start_date: 2015-04-21 · SFPI
- Permanent representative · Céline Vaessen
- Officer appointment: role: administrateur, term: 6 ans, start_date: 2015-04-21 · FRANFIN
- Permanent representative · Baudouin Dubuisson
- Officer appointment: role: administrateur, term: 6 ans, start_date: 2015-04-21 · François Blondel
- Officer appointment: role: administrateur, term: 6 ans, start_date: 2015-04-21 · MITISKA
- Permanent representative · ONALIM SPRL
- Permanent representative · Bernard Raevens
- Officer appointment: role: Administrateur Délégué, term: 6 ans, start_date: 2015-04-21 · Laurent Kosbach
- Officer appointment: role: administrateur, term: 6 ans, start_date: 2015-04-21 · ARPEGO SPRL
- Permanent representative · Pierre Joris
Technical details
{
"facts": [
{
"date": "2015-09-07",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 07/09/2015",
"value": "07/09/2015",
"object": null,
"subject": "e1"
},
{
"date": "2015-08-27",
"type": "filing",
"quote": "Greffe du Tribunal de Commerce de Li\u00E8ge - division Namur le 27 AO\u00DBT 2015",
"value": "27/08/2015",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Objet(s) de l\u0027acte :Confirmation du conseil d\u0027administration",
"value": "Confirmation du conseil d\u0027administration",
"object": null,
"subject": "e1"
},
{
"date": "2015-04-21",
"type": "general_meeting",
"quote": "DECISION DE L\u0027ASSEMBLEE GENERALE ORDINAIRE du 21/04/2015",
"value": "21/04/2015",
"object": null,
"subject": "e1"
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "A dater du 21/04/2015, le Conseil d\u0027Administration de Nanocyl, \u00E9lu pour 6 ans, se compose de 10: administrateurs : - La soci\u00E9t\u00E9 INNOSTE",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e2",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 INNOSTE ... repr\u00E9sent\u00E9e par Monsieur Jean Stephenne, pr\u00E9sident du Conseil d\u0027Administration",
"value": {
"role": "pr\u00E9sident du Conseil d\u0027Administration",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e3",
"_value_raw": {
"role": "pr\u00E9sident du Conseil d\u0027Administration",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 INNOSTE ... repr\u00E9sent\u00E9e par Monsieur Jean Stephenne",
"value": null,
"object": "e2",
"subject": "e3"
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 SAMANDA SA",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e4",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 SAMANDA SA ... repr\u00E9sent\u00E9e par Monsieur Christian Colson",
"value": null,
"object": "e4",
"subject": "e5"
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 NOMAINVEST",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e6",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 NOMAINVEST ... repr\u00E9sent\u00E9e par Monsieur Yves No\u00EBl",
"value": null,
"object": "e6",
"subject": "e7"
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "La SFPI",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e8",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"type": "permanent_representative",
"quote": "La SFPI ... repr\u00E9sent\u00E9e par Madame C\u00E9line Vaessen",
"value": null,
"object": "e8",
"subject": "e9"
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 FRANFIN",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e10",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 FRANFIN ... repr\u00E9sent\u00E9e par Monsieur Baudouin Dubuisson",
"value": null,
"object": "e10",
"subject": "e11"
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "Monsieur Fran\u00E7ois Blondel",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e12",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 MITISKA",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e13",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 MITISKA ... repr\u00E9sent\u00E9e par la soci\u00E9t\u00E9 ONALIM SPRL",
"value": null,
"object": "e13",
"subject": "e14"
},
{
"type": "permanent_representative",
"quote": "la soci\u00E9t\u00E9 ONALIM SPRL ... repr\u00E9sent\u00E9e par Monsieur Bernard Raevens",
"value": null,
"object": "e14",
"subject": "e15"
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "Monsieur Laurent Kosbach, CEO, Administrateur D\u00E9l\u00E9gu\u00E9",
"value": {
"role": "Administrateur D\u00E9l\u00E9gu\u00E9",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e16",
"_value_raw": {
"role": "Administrateur D\u00E9l\u00E9gu\u00E9",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"date": "2015-04-21",
"type": "officer_appointment",
"quote": "La soci\u00E9t\u00E9 ARPEGO SPRL",
"value": {
"role": "administrateur",
"term": "6 ans",
"start_date": "2015-04-21"
},
"object": null,
"subject": "e17",
"_value_raw": {
"role": "administrateur",
"term": "6 ans",
"start_date": "21/04/2015"
}
},
{
"type": "permanent_representative",
"quote": "La soci\u00E9t\u00E9 ARPEGO SPRL ... repr\u00E9sent\u00E9e par Monsieur Pierre Joris",
"value": null,
"object": "e17",
"subject": "e18"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 1973,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0476.998.785",
"kind": "company",
"name": "NANOCYL",
"attrs": {
"seat": "Rue de l\u0027Essor, 4 \u00E0 5060 - Sambreville",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
}
},
{
"id": "e2",
"kbo": "0876.616.318",
"kind": "company",
"name": "INNOSTE",
"attrs": {}
},
{
"id": "e3",
"kbo": null,
"kind": "person",
"name": "Jean Stephenne",
"attrs": {}
},
{
"id": "e4",
"kbo": "0480.028.848",
"kind": "company",
"name": "SAMANDA SA",
"attrs": {}
},
{
"id": "e5",
"kbo": null,
"kind": "person",
"name": "Christian Colson",
"attrs": {}
},
{
"id": "e6",
"kbo": "0460.996.458",
"kind": "company",
"name": "NOMAINVEST",
"attrs": {}
},
{
"id": "e7",
"kbo": null,
"kind": "person",
"name": "Yves No\u00EBl",
"attrs": {}
},
{
"id": "e8",
"kbo": "0253.445.063",
"kind": "company",
"name": "SFPI",
"attrs": {}
},
{
"id": "e9",
"kbo": null,
"kind": "person",
"name": "C\u00E9line Vaessen",
"attrs": {}
},
{
"id": "e10",
"kbo": "0466.136.567",
"kind": "company",
"name": "FRANFIN",
"attrs": {}
},
{
"id": "e11",
"kbo": null,
"kind": "person",
"name": "Baudouin Dubuisson",
"attrs": {}
},
{
"id": "e12",
"kbo": null,
"kind": "person",
"name": "Fran\u00E7ois Blondel",
"attrs": {}
},
{
"id": "e13",
"kbo": "0465.509.730",
"kind": "company",
"name": "MITISKA",
"attrs": {}
},
{
"id": "e14",
"kbo": "0826.735.750",
"kind": "company",
"name": "ONALIM SPRL",
"attrs": {}
},
{
"id": "e15",
"kbo": null,
"kind": "person",
"name": "Bernard Raevens",
"attrs": {}
},
{
"id": "e16",
"kbo": null,
"kind": "person",
"name": "Laurent Kosbach",
"attrs": {}
},
{
"id": "e17",
"kbo": "0539.765.507",
"kind": "company",
"name": "ARPEGO SPRL",
"attrs": {}
},
{
"id": "e18",
"kbo": null,
"kind": "person",
"name": "Pierre Joris",
"attrs": {}
}
]
}11-06-2015 Registered office moved from Lontzen to Eupen
- Busch 12 -4710 Lontzen → Eichenberg 41 à 4700 Eupen
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Eichenberg 41 \u00E0 4700 Eupen",
"city": "Eupen",
"region": "waals_gewest",
"street": "Eichenberg",
"country": "BE",
"postcode": "4700",
"box_number": null,
"street_number": "41",
"locality_suffix": null
},
"old_address": {
"raw": "Busch 12 -4710 Lontzen",
"city": "Lontzen",
"region": "waals_gewest",
"street": "Busch",
"country": "BE",
"postcode": "4710",
"box_number": null,
"street_number": "12",
"locality_suffix": null
},
"effective_date": "2015-01-30",
"evidence_quote": "Du proc\u00E8s-verbal de la r\u00E9union du conseil d\u0027administration du 30 janvier 2015 ressort que le conseil d\u00E9cide de transf\u00E9rer le si\u00E8ge social \u00E0 l\u0027adresse suivante: Eichenberg 41 \u00E0 4700 Eupen.",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
},
{
"kind": "zetel_clause_amendment_no_move",
"seat_type": "siege_social",
"new_address": {
"raw": "Busch 12 -4710 Lontzen",
"city": "Lontzen",
"region": "waals_gewest",
"street": "Busch",
"country": "BE",
"postcode": "4710",
"box_number": null,
"street_number": "12",
"locality_suffix": null
},
"old_address": {
"raw": "Busch 12 -4710 Lontzen",
"city": "Lontzen",
"region": "waals_gewest",
"street": "Busch",
"country": "BE",
"postcode": "4710",
"box_number": null,
"street_number": "12",
"locality_suffix": null
},
"effective_date": "2015-05-04",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale confirme que le mandat des administrateurs suivants prend fin \u00E0 ce jour: Micam s.p.r.l. repr\u00E9sent\u00E9e par Madame Isabelle Jortay-No\u00EBl et NMF s.a. repr\u00E9sent\u00E9e par Monsieur Yves No\u00EBl et Madame Catherine Schoonbroodt-No\u00EBl",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "N.M.F. s.a., repr\u00E9sent\u00E9e par M. Yves No\u00EBl",
"firm_city": null,
"firm_name": null,
"office_city": "Eupen",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2015-06-11",
"filing_date": "2015-05-04",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "jaarvergadering",
"date": "2015-05-04",
"unanimous": true
},
"subject_company": {
"kbo": "0460.996.458",
"name_full": "NOMAINVEST",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Yves No\u00EBl",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur d\u00E9l\u00E9gu\u00E9"
},
"co_filed_documents": [
"Proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires du 4 mai 2015",
"Proc\u00E8s-verbal de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires du 5 mai 2014",
"Proc\u00E8s-verbal de la r\u00E9union du conseil d\u0027administration du 30 janvier 2015"
]
}| Legal nameDE | NOMAINVEST |